<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.934143</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20250506141422</marc:controlfield>
    <marc:controlfield tag="006">m     o  d f      </marc:controlfield>
    <marc:controlfield tag="007">cr mn|||||||||</marc:controlfield>
    <marc:controlfield tag="008">240219e201303  onca    o    f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
      <marc:subfield code="e">rda</marc:subfield>
      <marc:subfield code="c">CaOODSP</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="045" ind1=" " ind2=" ">
      <marc:subfield code="a">y0y1</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H14-582/2013E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Final audit report : </marc:subfield>
      <marc:subfield code="b">audit of the transfer payment to the Canadian Agency for Drugs and Technologies in Health.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="7">
      <marc:subfield code="a">Audit of the transfer payment to the CADTH : </marc:subfield>
      <marc:subfield code="b">final audit report</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health Canada = Santé Canada, </marc:subfield>
      <marc:subfield code="c">March 2013.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (i, 21 pages) : </marc:subfield>
      <marc:subfield code="b">colour illustration + </marc:subfield>
      <marc:subfield code="e">management reponse and action plan (1 page)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Rapport de vérification final : vérification du paiement de transfert à l'Agence canadienne des médicaments et des technologies de la santé.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Cover title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"The proper management of government funds is an important aspect of grant and contribution oversight. This audit focussed on a conditional grant for $87.5M which was paid over a fiveyear period ending March 31, 2013 to the Canadian Agency for Drugs and Technologies in Health (the recipient). The recipient has received the funds from Health Canada to provide information and advice to health care system decision makers about the effectiveness and efficiency of drugs, medical devices and other health technologies. As the expiration of the conditional grant approaches, the Strategic Policy Branch will be moving to a five-year contribution agreement. Health Canada's conditional grant accounts for approximately 78 percent of the recipient's funding; provinces and territories account for the remaining 22 percent. The objectives of the audit are to determine whether the Strategic Policy Branch has put in place an effective management control framework for the oversight and management of the funding agreement and whether the Canadian Agency for Drugs and Technologies in Health has complied with the terms and conditions of the funding agreement. The audit involved the conduct of sufficient and appropriate procedures and the gathering of evidence to support the audit conclusion. …"--Executive summary, page i.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="610" ind1="2" ind2="0">
      <marc:subfield code="a">Canadian Agency for Drugs and Technologies in Health</marc:subfield>
      <marc:subfield code="x">Finance</marc:subfield>
      <marc:subfield code="x">Auditing.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="610" ind1="1" ind2="0">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Health Canada</marc:subfield>
      <marc:subfield code="x">Auditing.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Health Canada. </marc:subfield>
      <marc:subfield code="b">Portfolio Audit and Accountability Bureau, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Rapport de vérification final : </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.934322</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">149 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2024/sc-hc/H14-582-2013-eng.pdf</marc:subfield>
      <marc:subfield code="z">(final audit report)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">14 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2024/sc-hc/H14-582-2013-1-eng.pdf</marc:subfield>
      <marc:subfield code="z">(management reponse and action plan)</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2=" ">
      <marc:subfield code="q">HTML</marc:subfield>
      <marc:subfield code="s">N/A</marc:subfield>
      <marc:subfield code="u">https://www.canada.ca/en/health-canada/corporate/about-health-canada/reports-publications/audit-reports/2013/management-response-action-plan-audit-transfer-payment-canadian-agency-drugs-technologies-health.html</marc:subfield>
      <marc:subfield code="z">(management reponse and action plan)</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
